Literature DB >> 15827200

Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).

Jayati Mullick1, Akhilesh K Singh, Yogesh Panse, Vivekanand Yadav, John Bernet, Arvind Sahu.   

Abstract

Recently it has been shown that kaposica, an immune evasion protein of Kaposi's sarcoma-associated herpesvirus, inactivates complement by acting on C3-convertases by accelerating their decay as well as by acting as a cofactor in factor I-mediated inactivation of their subunits C3b and C4b. Here, we have mapped the functional domains of kaposica. We show that SCRs 1 and 2 (SCRs 1-2) and 1-4 are essential for the classical and alternative pathway C3-convertase decay-accelerating activity (DAA), respectively, while the SCRs 2-3 are required for factor I cofactor activity (CFA) for C3b and C4b. SCR 3 and SCRs 1 and 4, however, contribute to optimal classical pathway DAA and C3b CFA, respectively. Binding data show that SCRs 1-4 and SCRs 1-2 are the smallest structural units required for measuring detectable binding to C3b and C4b, respectively. The heparin-binding site maps to SCR 1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827200      PMCID: PMC1082731          DOI: 10.1128/JVI.79.9.5850-5856.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense.

Authors:  S A Smith; N P Mullin; J Parkinson; S N Shchelkunov; A V Totmenin; V N Loparev; R Srisatjaluk; D N Reynolds; K L Keeling; D E Justus; P N Barlow; G J Kotwal
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding.

Authors:  Q Pan; R O Ebanks; D E Isenman
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

Review 3.  Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.

Authors:  D Hourcade; M K Liszewski; M Krych-Goldberg; J P Atkinson
Journal:  Immunopharmacology       Date:  2000-08

4.  Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.

Authors:  M Krych-Goldberg; R E Hauhart; V B Subramanian; B M Yurcisin; D L Crimmins; D E Hourcade; J P Atkinson
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

5.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Structural requirements for the complement regulatory activities of C4BP.

Authors:  A M Blom; L Kask; B Dahlbäck
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

7.  Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35).

Authors:  A E Oran; D E Isenman
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

8.  Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.

Authors:  W G Brodbeck; D Liu; J Sperry; C Mold; M E Medof
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

Review 9.  Viral interference with antibody and complement.

Authors:  J Lubinski; T Nagashunmugam; H M Friedman
Journal:  Semin Cell Dev Biol       Date:  1998-06       Impact factor: 7.727

Review 10.  Viral mechanisms of immune evasion.

Authors:  A Alcami; U H Koszinowski
Journal:  Trends Microbiol       Date:  2000-09       Impact factor: 17.079

View more
  14 in total

1.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins.

Authors:  Avneesh Kumar Gautam; Yogesh Panse; Payel Ghosh; Malik Johid Reza; Jayati Mullick; Arvind Sahu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-29       Impact factor: 11.205

Review 3.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Kaposi's sarcoma-associated herpesvirus and innate immunity.

Authors:  John A West; Blossom Damania
Journal:  Future Virol       Date:  2010-03-01       Impact factor: 1.831

5.  Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.

Authors:  Linda Mark; David G Proctor; David J Blackbourn; Anna M Blom; O Brad Spiller
Journal:  Immunology       Date:  2007-08-30       Impact factor: 7.397

6.  Dissection of functional sites in herpesvirus saimiri complement control protein homolog.

Authors:  Malik Johid Reza; Ashish Kamble; Muzammil Ahmad; Musti V Krishnasastry; Arvind Sahu
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.

Authors:  Viveka Nand Yadav; Kalyani Pyaram; Jayati Mullick; Arvind Sahu
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.

Authors:  Akhilesh K Singh; Viveka Nand Yadav; Kalyani Pyaram; Jayati Mullick; Arvind Sahu
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

9.  MHV68 complement regulatory protein facilitates MHV68 replication in primary macrophages in a complement independent manner.

Authors:  Vera L Tarakanova; Jerome M Molleston; Megan Goodwin; Herbert W Virgin
Journal:  Virology       Date:  2009-11-11       Impact factor: 3.616

10.  Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.

Authors:  O B Spiller; L Mark; C E Blue; D G Proctor; J A Aitken; A M Blom; D J Blackbourn
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.